Grant of Restricted Share Units
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Grant of Restricted Share Units
Filed with SSE · · 4 pages · Chinese
6ix is checking which company filed this.
Earlier from BeOne Medicines
- Voluntary Announcement on Progress of Clinical Trial of BRUKINSA (Zanubrutinib Capsules)
- Announcement on the Handling of Relevant Tax Matters
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
- Report for Q1 2026
Later from BeOne Medicines
- Announcement on Voluntary Disclosure of Holding Conference Call for Company Performance
- Announcement on Voluntary Disclosure of Adjustment of Operating Performance Forecast for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Semi-annual Report for 2026
- (688235)"BEONE MEDICINES LTD."Announcement on Voluntary Disclosure of Holding the Earnings Conference Call
Follow BeOne Medicines into a list and get an email when it puts out news.
Follow BeOne Medicines